The Delirium Rating Scale -: Its use in consultation-liaison research

被引:78
作者
Trzepacz, PT [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Sch Med, Jackson, MS 39216 USA
关键词
D O I
10.1016/S0033-3182(99)71235-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In addition to diagnostic criteria, delirium research requires standardized instruments to measure symptoms. This article reviews the literature aborts the Delirium Rating Scale (DRS), the most widely used scale to assess delirium that has been translated into at least seven other languages. The DRS has 10 items and is clinician-rated, but 7- or 8-item subscale adaptations have been used for repeated measurements. It has high scale characteristics, including internal consistency validity, specificity, sensitivity and interrater reliability. The DRS distinguishes delirious from demented, schizophrenic, and depressed patients and is more accurate than cognitive tests in identifying delirium. Scores are sensitive to treatment of delirium. Principal components analyses find one underlying dimension that can be subdivided into two or three components. The DRS has been used ill studies of phenomenology: physiology: treatment, outcome, and at-risk populations. Tables summarize details from various studies. The DRS is used clinically and in research. It is currently being revised to enhance its use in phenomenologic and treatment research.
引用
收藏
页码:193 / 204
页数:12
相关论文
共 35 条
[1]  
Albert M S, 1992, J Geriatr Psychiatry Neurol, V5, P14
[2]  
Albronda T, 1996, Ned Tijdschr Geneeskd, V140, P1993
[3]  
American Psychiatric Association, 1994, DIAGN STAT MAN MENTA
[4]  
[Anonymous], ANN REP PHARMACOPSYC
[5]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[6]  
BERRGREN D, 1987, ANESTH ANALG, V1394, P497
[7]   The Memorial Delirium Assessment Scale [J].
Breitbart, W ;
Rosenfeld, B ;
Roth, A ;
Smith, MJ ;
Cohen, K ;
Passik, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (03) :128-137
[8]  
Breitbart W, 1996, AM J PSYCHIAT, V153, P231
[9]  
DIMARTINI A, 1991, TRANSPLANT P, V23, P3179
[10]   Neuropsychiatric side effects of FK506 vs. cyclosporine A - First-week postoperative findings [J].
DiMartini, AF ;
Trzepacz, PT ;
Pajer, KA ;
Faett, D ;
Fung, J .
PSYCHOSOMATICS, 1997, 38 (06) :565-569